Loading...
XNYS
SYK
Market cap106bUSD
Oct 08, Last price  
276.97USD
1D
0.57%
1Q
-16.01%
Jan 2017
131.17%
Name

Stryker Corp

Chart & performance

D1W1MN
XNYS:SYK chart
P/E
32.71
P/S
4.23
EPS
8.47
Div yield, %
1.23%
Shrs. gr., 5y
0.10%
Rev. gr., 5y
11.84%
Revenues
25.12b
+11.16%
5,405,600,0006,000,500,0006,718,200,0006,723,100,0007,320,000,0008,307,000,0008,657,000,0009,021,000,0009,675,000,0009,946,000,00011,325,000,00012,444,000,00013,601,000,00014,884,000,00014,351,000,00017,108,000,00018,449,000,00020,498,000,00022,595,000,00025,116,000,000
Net income
3.25b
+8.45%
777,700,0001,017,400,0001,147,800,0001,107,400,0001,273,400,0001,345,000,0001,298,000,0001,006,000,000515,000,0001,439,000,0001,647,000,0001,020,000,0003,553,000,0002,083,000,0001,599,000,0001,994,000,0002,358,000,0003,165,000,0002,993,000,0003,246,000,000
CFO
5.04b
+18.91%
867,300,0001,028,300,0001,175,900,0001,460,700,0001,547,400,0001,434,000,0001,657,000,0001,886,000,0001,782,000,000899,000,0001,915,000,0001,559,000,0002,610,000,0002,191,000,0003,277,000,0003,263,000,0002,624,000,0003,711,000,0004,242,000,0005,044,000,000
Dividend
Sep 30, 20260.88 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.

Related entities

Subsidiaries (22)
STRYKER IFSC DESIGNATED ACTIVITY COMPANY
STRYKER LEIBINGER GMBH & CO. KG

Key people

Spencer Stiles
President, Chief Operating Officer · since 2026
Chairman of the Board, President, Chief Executive Officer · since 2021
Dylan Crotty
Group President, Orthopaedics · since 2026
Viju Menon
Group President - Global Quality and Operations · since 2018
J. Andrew Pierce
Group President - MedSurg and Neurotechnology · since 2021
Yin Becker
Vice President - Chief Corporate Affairs Officer · since 2016
Chief Accounting Officer, Vice President · since 2021
M. Kathryn Fink
Chief Human Resources Officer, Vice President · since 2016
Robert Fletcher
Vice President, Chief Legal Officer · since 2019
Preston Wells
Chief Financial Officer, Vice President · since 2025
Jason Beach
Vice President of Investor Relations · since 2022
Mary Brainerd
Independent Director · since 2017
Giovanni Caforio
Independent Director · since 2020
Lead Independent Director · since 2022
Rachel Ruggeri
Independent Director · since 2024
Independent Director · since 2013
Lisa Skeete Tatum
Independent Director · since 2020
Ronda Stryker
Independent Director · since 1984
Independent Director · since 2018
IPO date
Mar 17, 1980
Employees
51,000
Domiciled in
US
Incorporated in
US
Legal address
C/O C T CORPORATION SYSTEM
40600 ANN ARBOR RD E
STE 201
PLYMOUTH, MI 48170-4675
US
Headquarters
2825 AIRVIEW BOULEVARD
PORTAGE, MI 49002
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT